CATALYSIS Advises Microdialysis Pioneer CMA Microdialysis AB on the Sale of its Preclinical Microdialysis Assets to Harvard Bioscience, Inc.
CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive strategic advisor to CMA Microdialysis AB on the sale of its preclinical microdialysis assets and related intellectual property to Harvard Bioscience, Inc. Financial terms were not disclosed. Read more →